Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-10-27

Clinical Trial Update: Closed-loop Control of Postprandial Glucose Levels in Children and Adults With Type 1 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating closed-loop control of postprandial glucose in children and adults with Type 1 diabetes has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Institut de Recherches Cliniques de Montreal | Conditions: Type 1 Diabetes | Phase 2 | Status: WITHDRAWN